LTN Event Explored Exciting Advancements in Drug Discovery
News Nov 16, 2005
The event - “Technology Developments in Drug Discovery: Advancements and Challenges in Structural Biology” was held at The Royal Institution of Great Britain on Wednesday 26 October, and attracted industry leaders and researchers from across London and the South-East.
The London Technology Network event focussed specifically on techniques such as X-ray crystallography, which in the last two decades has created major new advancements in drug discovery.
The event highlighted the latest research as well as exploring the ongoing challenges and bottlenecks facing the industry.
Professor So Iwata of Imperial College London addressed the challenge of membrane protein targets – and outlined exciting new techniques for solving GPCR structures.
Dr Jeff Yon of Astex assessed the technical challenges facing the new company, and highlighted the importance of academic collaborations, while Dr Richard Pauptit of AstraZeneca analysed how structural biology capabilities are used within a multinational pharmaceutical company.
The event was also an opportunity for academic scientists to present the latest research in the area to industry leaders, in the form of posters displayed on the night and through networking.
Nine posters on the newest technologies were presented by LTN Business Fellows from institutions such as Imperial College and the University College London.
Simon Gibbons and Robert Harvey of The School of Pharmacy, University of London presented a poster of their work on novel antibacterials from plants to be used in fighting MRSA.
Kimberly Watson of the Biocentre at the University of Reading showcased the latest advancements in mass spectrometry and large-scale fermentation, while Célia Plisson from the School of Crystallography at Birkbeck, University of London showed new ways of solving protein expression problems.
The next LTN event will be held on 23 November on the subject of Grid Computing and Web Services.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.
Faster Test for Cannabis Quality, Potency DevelopedNews
Traditional tests can take upwards of 20 minutes to perform, this new one can be done in under seven.READ MORE